GO:0005004 GPI-linked ephrin receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005004 (GPI-linked ephrin receptor activity) is a molecular function defined as combining with a GPI-anchored ephrin to initiate a change in cell activity.
• The term is synonymous with GPI-linked Eph receptor activity and is classified under the molecular_function aspect of the Gene Ontology.
• EphA receptors such as EphA2 and EphA8 are activated by GPI-anchored ephrin-A ligands, including ephrin-A1 and ephrin-A4.
• GPI-anchored ephrins can also signal in reverse, a process that requires SRC family kinase activity and restricts neuronal migration.
• Ephrin-A1 is released from cancer cells in multiple soluble forms by matrix metalloproteases, influencing receptor activation.
• Dysregulated GPI-linked ephrin receptor activity is implicated in ovarian carcinoma and other cancers, making it a target for functional studies.
Description
GPI-linked ephrin receptor activity (GO:0005004) is a molecular function that describes the binding of a GPI-anchored ephrin ligand to its receptor, thereby initiating a change in cell activity. This activity is central to Eph receptor signaling, a key axis in cell migration, axon guidance, and tissue patterning. The term is synonymous with GPI-linked Eph receptor activity and is defined in QuickGO as combining with a GPI-anchored ephrin to initiate a change in cell activity. Researchers study this function to understand how extracellular cues are translated into intracellular responses during development and disease. The receptors that carry this activity are typically EphA family receptor tyrosine kinases, such as EphA2 and EphA8, which bind GPI-anchored ephrin-A ligands like ephrin-A1 and ephrin-A4. Because ephrins are membrane-tethered via a glycosylphosphatidylinositol (GPI) anchor, their interaction with Eph receptors occurs at cell-cell contacts, enabling bidirectional signaling. This unique geometry allows for both forward signaling through the Eph receptor and reverse signaling through the ephrin ligand, a phenomenon that has been demonstrated in neuronal migration and cancer cell communication. Understanding GPI-linked ephrin receptor activity is important for deciphering how cells interpret positional information and how misregulation contributes to pathologies such as cancer and developmental disorders. For example, EphA2 activation by monomeric ephrin-A1 on supported membranes has been biophysically characterized, revealing mechanistic details of receptor clustering and activation. In ovarian carcinomas, gene expression patterns of Eph receptors and ephrins are altered, suggesting a role in tumor progression. This article provides a comprehensive overview of the ontology, mechanisms, key genes, disease links, and research methods relevant to GO:0005004.
GPI-linked ephrin receptor activity At A Glance
| GO ID | GO:0005004 |
|---|---|
| GO term | GPI-linked ephrin receptor activity |
| Ontology | molecular_function |
| Synonym | GPI-linked Eph receptor activity |
| Major function | Binding to GPI-anchored ephrin ligands to initiate intracellular signaling |
| Receptor family | Eph receptor tyrosine kinases (e.g., EphA2, EphA8) |
| Ligand family | GPI-anchored ephrin-A ligands (e.g., ephrin-A1, ephrin-A4) |
| Signaling direction | Forward signaling through the Eph receptor; can also participate in bidirectional signaling |
| Cellular context | Cell-cell contact sites, membrane microdomains |
What Is GO:0005004?
GPI-linked ephrin receptor activity (GO:0005004) is defined as the function of combining with a GPI-anchored ephrin to initiate a change in cell activity. In other words, it is the receptor-side activity that occurs when an Eph receptor tyrosine kinase binds to an ephrin ligand that is attached to the cell membrane via a GPI anchor. This binding event triggers intracellular signaling cascades that alter cell behavior, such as migration, adhesion, or proliferation. The term is specific to the receptor activity and does not describe the ligand's own signaling (reverse signaling), which is covered by separate GO terms.
Why Is GPI-linked ephrin receptor activity Important in Cell Biology?
GPI-linked ephrin receptor activity is a critical molecular function that governs how cells respond to GPI-anchored ephrin cues during development and tissue homeostasis. It is essential for axon guidance, cell migration, and boundary formation, and its dysregulation is linked to cancer progression and metastatic spread. Because this activity is mediated by Eph receptors, which are frequently overexpressed or mutated in human tumors, it represents a promising target for therapeutic intervention and a key focus for functional genomics studies.
• Regulates axon guidance and neuronal migration during embryonic development.
• Controls cell adhesion and repulsion, influencing tissue boundary formation.
• Implicated in cancer progression, including ovarian carcinoma.
• Mediates bidirectional signaling between adjacent cells via GPI-anchored ephrins.
• Requires SRC family kinase activity for reverse signaling in some contexts.
• Ephrin-A1 release by matrix metalloproteases modulates receptor activation in cancer.
• Provides a model for studying membrane-bound ligand-receptor interactions.
• Potential target for therapeutic antibodies and small molecules in oncology.
• Key to understanding cell-cell communication in development and disease.
• Enables functional screens for genes affecting migration and invasion.
What Happens During GPI-linked ephrin receptor activity?
Ligand binding and receptor activation
In simple terms: A GPI-anchored ephrin on one cell binds to an Eph receptor on another cell, switching the receptor on.
The activity begins when a GPI-anchored ephrin ligand, such as ephrin-A1 or ephrin-A4, engages an Eph receptor tyrosine kinase, typically EphA2 or EphA8, on the surface of a neighboring cell. This binding event induces receptor clustering and autophosphorylation, initiating intracellular signaling. Biophysical studies using supported membranes have shown that monomeric ephrin-A1 can activate EphA2, providing mechanistic insight into the minimal requirements for receptor activation.
Forward signaling through the Eph receptor
In simple terms: Once activated, the Eph receptor sends signals into its own cell, changing how the cell moves or sticks.
Upon ligand binding, the Eph receptor undergoes autophosphorylation on tyrosine residues, creating docking sites for SH2-domain-containing proteins. This forward signaling cascade modulates cytoskeletal dynamics, cell adhesion, and migration. In growth cones, coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on navigation from distinct membrane domains, highlighting the spatial complexity of forward signaling.
Reverse signaling through the GPI-anchored ephrin
In simple terms: The ephrin side can also send signals back into its own cell, which requires specific kinases.
GPI-anchored ephrins are not merely passive ligands; they can transduce reverse signals into the cell that presents them. In Manduca, reverse signaling via a GPI-linked ephrin prevents midline crossing by migratory neurons during embryonic development. This reverse signaling requires a SRC family kinase to restrict neuronal migration in vivo, demonstrating that the GPI-anchored ephrin can actively participate in signaling.
Proteolytic release and modulation
In simple terms: Enzymes can cut the ephrin off the membrane, releasing soluble forms that can still affect receptor activity.
Ephrin-A1 is released in three forms from cancer cells by matrix metalloproteases, generating soluble ligands that can modulate Eph receptor activation in a paracrine or autocrine manner. This proteolytic processing adds another layer of regulation to GPI-linked ephrin receptor activity, influencing both forward and reverse signaling in the tumor microenvironment.
Key Genes Involved in GO:0005004 GPI-linked ephrin receptor activity
The following genes encode the receptors and ligands that mediate GPI-linked ephrin receptor activity, along with related signaling components.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EPHA2 | Ephrin type-A receptor 2; binds GPI-anchored ephrin-A ligands | Biophysical studies of receptor activation; cancer target |
| EPHA8 | Ephrin type-A receptor 8; binds ephrin-A1 and ephrin-A4 | Characterization of ligand specificity |
| EFNA1 | Ephrin-A1; GPI-anchored ligand for EphA receptors | Ligand for EphA2; released by MMPs in cancer |
| EFNA4 | Ephrin-A4; GPI-anchored ligand for EphA8 | Ligand binding studies |
| EFNA5 | Ephrin-A5; GPI-anchored ligand | Growth cone navigation |
| EPHA4 | Ephrin type-A receptor 4 | Opposing actions on growth cones |
| EPHA7 | Ephrin type-A receptor 7 | Neuronal migration and cancer |
| EPHB1 | Ephrin type-B receptor 1 | Related Eph receptor family member |
| EPHB2 | Ephrin type-B receptor 2 | Related Eph receptor family member |
| SRC | SRC proto-oncogene, non-receptor tyrosine kinase | Required for reverse signaling |
| FYN | FYN proto-oncogene, Src family tyrosine kinase | Potential SRC family kinase in reverse signaling |
| MMP2 | Matrix metallopeptidase 2 | Releases ephrin-A1 from cancer cells |
| MMP9 | Matrix metallopeptidase 9 | Releases ephrin-A1 from cancer cells |
| ADAM10 | ADAM metallopeptidase domain 10 | Potential sheddase for ephrins |
| ADAM17 | ADAM metallopeptidase domain 17 | Potential sheddase for ephrins |
| RAC1 | Rac family small GTPase 1 | Downstream of Eph receptor signaling |
| RHOA | Ras homolog family member A | Downstream of Eph receptor signaling |
| CDC42 | Cell division cycle 42 | Downstream of Eph receptor signaling |
How Is GPI-linked ephrin receptor activity Regulated?
GPI-linked ephrin receptor activity is regulated at multiple levels. Ligand availability is controlled by proteolytic shedding; ephrin-A1 is released in three forms from cancer cells by matrix metalloproteases, which can either activate or dampen signaling depending on context. Receptor clustering and activation are influenced by membrane organization, as shown by supported membrane studies with monomeric ephrin-A1. Reverse signaling through GPI-anchored ephrins requires SRC family kinase activity, adding a phosphorylation-dependent regulatory layer. Additionally, the spatial segregation of receptors and ligands on distinct membrane domains can dictate opposing actions on growth cone navigation.
GPI-linked ephrin receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EPHA2 | Ovarian carcinoma, cancer progression | KO and overexpression in ovarian cancer cell lines |
| EFNA1 | Tumor angiogenesis, cancer metastasis | Point mutation of MMP cleavage sites; knock-in of soluble forms |
| EPHA8 | Neuronal development | KO mouse models; ligand binding assays |
| SRC | Neuronal migration disorders | Kinase-dead knock-in; KO in neuronal cells |
| EPHA4 | Axon guidance defects | KO and conditional KO in mouse |
Cancer
Dysregulated GPI-linked ephrin receptor activity is implicated in cancer. Gene expression patterns in ovarian carcinomas show altered levels of Eph receptors and ephrins, suggesting a role in tumor progression. Ephrin-A1 is released from cancer cells by matrix metalloproteases, which can promote tumor angiogenesis and metastasis. EphA2, a major receptor for GPI-anchored ephrins, is overexpressed in many cancers and is a target for therapeutic development.
Developmental disorders
Proper GPI-linked ephrin receptor activity is essential for embryonic development. In Manduca, reverse signaling via a GPI-linked ephrin prevents midline crossing by migratory neurons, and disruption leads to aberrant neuronal migration. SRC family kinase-dependent reverse signaling restricts neuronal migration in vivo, highlighting the importance of this pathway in nervous system development. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation, which is critical for correct wiring of the nervous system.
Neurological disorders
Alterations in Eph/ephrin signaling have been associated with neurological conditions, although direct links to GO:0005004 are still being elucidated. The role of GPI-anchored ephrins in neuronal migration and axon guidance suggests that perturbations could contribute to neurodevelopmental disorders.
From GPI-linked ephrin receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does EPHA2 mediate ephrin-A1-induced migration? | EPHA2 knockout in cancer cell lines |
| What is the role of ephrin-A1 shedding in tumor growth? | Point mutation of MMP cleavage sites in EFNA1 |
| How does reverse signaling affect neuronal migration? | Knock-in of kinase-dead SRC in neurons |
| Can soluble ephrin-A1 activate EphA2 in trans? | Overexpression of soluble ephrin-A1 in cancer cells |
| What is the spatiotemporal dynamics of EphA2 activation? | Tagged knock-in of EPHA2 with fluorescent protein |
| Which genes modulate GPI-linked ephrin receptor activity? | CRISPR library screening in migration assays |
How to Study the GPI-linked ephrin receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance | Binding affinity between Eph receptor and ephrin ligand | Characterizing GPI-linked ephrin receptor activity |
| Immunoblotting | Receptor phosphorylation and downstream signaling | Assessing activation of EphA2 by ephrin-A1 |
| Immunofluorescence | Subcellular localization of receptors and ligands | Studying membrane domain segregation |
| CRISPR knockout screening | Genes required for ephrin-induced phenotypes | Identifying modulators of migration |
| Mass spectrometry | Identification of ephrin-A1 cleavage products | Analyzing MMP-mediated shedding |
| Neuronal migration assay | Reverse signaling-dependent cell migration | Studying GPI-anchored ephrin function |
| Co-immunoprecipitation | Protein-protein interactions | Detecting Eph receptor complexes |
| RNA-seq | Transcriptional changes upon receptor activation | Profiling downstream gene expression |
Biochemical binding assays
Receptor-ligand interactions can be measured using surface plasmon resonance, isothermal titration calorimetry, or supported membrane assays. For example, monomeric ephrin-A1 on supported membranes has been used to activate EphA2 and study the biophysics of receptor clustering.
Cell-based signaling assays
Phosphorylation of Eph receptors and downstream effectors can be assessed by immunoblotting and immunofluorescence. Reverse signaling through GPI-anchored ephrins can be monitored by SRC family kinase activation and neuronal migration assays.
Genetic screens
CRISPR knockout libraries can be used to identify genes that modulate GPI-linked ephrin receptor activity. For instance, ovarian carcinoma gene expression patterns have been analyzed to find correlations with Eph/ephrin signaling.
Proteolytic processing analysis
Matrix metalloprotease-mediated release of ephrin-A1 can be studied by immunoprecipitation and mass spectrometry. Three forms of released ephrin-A1 have been characterized from cancer cells.
How CRISPR Can Be Used to Study GO:0005004 GPI-linked ephrin receptor activity
Knockout
CRISPR knockout of EPHA2, EFNA1, or SRC can abolish GPI-linked ephrin receptor activity, enabling loss-of-function studies in cancer and neuronal cells. For example, knocking out EPHA2 in ovarian cancer cell lines can test its role in migration and proliferation.
Point Mutation
Point mutations can be introduced to disrupt specific residues, such as the MMP cleavage site in ephrin-A1, to study the impact of shedding on receptor activation. Kinase-dead mutations in SRC can dissect reverse signaling requirements.
Knock-in
Knock-in of tagged versions of EPHA2 or EFNA1 allows real-time imaging of receptor-ligand dynamics. For instance, a fluorescently tagged EphA2 knock-in can reveal clustering at cell-cell contacts.
Overexpression
Overexpression of ephrin-A1 or EphA2 can amplify signaling and model cancer-associated upregulation. This approach has been used to study ligand release and receptor activation in tumor cells.
How EDITGENE Supports GPI-linked ephrin receptor activity Research
Researchers studying GPI-linked ephrin receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor activation, downstream signaling, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to accelerate these functional studies.
Contact EDITGENE today to design your custom CRISPR model for GPI-linked ephrin receptor activity research.
Frequently Asked Questions About GPI-linked ephrin receptor activity
What is GO:0005004?
GO:0005004 is the Gene Ontology molecular function term for GPI-linked ephrin receptor activity, defined as combining with a GPI-anchored ephrin to initiate a change in cell activity.
What genes are involved in GPI-linked ephrin receptor activity?
Key genes include EPHA2, EPHA8, EFNA1, EFNA4, and SRC, among others.
What is the synonym for GO:0005004?
The synonym is GPI-linked Eph receptor activity.
Which receptors bind GPI-anchored ephrins?
EphA receptors such as EphA2 and EphA8 bind GPI-anchored ephrin-A ligands like ephrin-A1 and ephrin-A4.
How is GPI-linked ephrin receptor activity regulated?
It is regulated by ligand shedding via matrix metalloproteases, receptor clustering, and SRC family kinase activity for reverse signaling.
What diseases are associated with GPI-linked ephrin receptor activity?
It is implicated in cancers such as ovarian carcinoma and in developmental disorders affecting neuronal migration.
What methods are used to study GPI-linked ephrin receptor activity?
Common methods include surface plasmon resonance, immunoblotting, CRISPR screens, and neuronal migration assays.
Can GPI-anchored ephrins signal in reverse?
Yes, reverse signaling through GPI-anchored ephrins requires SRC family kinase activity and can restrict neuronal migration.
How is ephrin-A1 released from cells?
Ephrin-A1 is released in three forms from cancer cells by matrix metalloproteases.
What CRISPR models are available for studying this activity?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes like EPHA2, EFNA1, and SRC.
Conclusion
GPI-linked ephrin receptor activity (GO:0005004) is a fundamental molecular function that mediates cell-cell communication through Eph receptor tyrosine kinases and GPI-anchored ephrin ligands. Its roles in neuronal migration, axon guidance, and cancer progression make it a critical area of research. Understanding its regulation and downstream effects can reveal new therapeutic targets and advance developmental biology.
References
- 1. Xu Q et al.. 2011. EphA2 receptor activation by monomeric Ephrin-A1 on supported membranes.. Biophys J 101(11):2731-9 PMID: 22261062
- 2. Choi S et al.. 1999. Characterization of ephrin-A1 and ephrin-A4 as ligands for the EphA8 receptor protein tyrosine kinase.. Mol Cells 9(4):440-5 PMID: 10515610
- 3. Schaner ME et al.. 2003. Gene expression patterns in ovarian carcinomas.. Mol Biol Cell 14(11):4376-86 PMID: 12960427
- 4. Coate TM et al.. 2008. Reverse signaling via a glycosyl-phosphatidylinositol-linked ephrin prevents midline crossing by migratory neurons during embryonic development in Manduca.. J Neurosci 28(15):3846-60 PMID: 18400884
- 5. Coate TM et al.. 2009. Reverse signaling by glycosylphosphatidylinositol-linked Manduca ephrin requires a SRC family kinase to restrict neuronal migration in vivo.. J Neurosci 29(11):3404-18 PMID: 19295147
- 6. Beauchamp A et al.. 2012. EphrinA1 is released in three forms from cancer cells by matrix metalloproteases.. Mol Cell Biol 32(16):3253-64 PMID: 22688511
- 8. Marquardt T et al.. 2005. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains.. Cell 121(1):127-39 PMID: 15820684
